Campus alert status is green: For the latest UMMS campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

Funding Opportunities


Here you will find a complete list of all available funding opportunities broken out by topic.  Each opportunity has a date, funding and a clickable link to learn more.

Resources

It is important that anyone submitting check with the  Office of Research  to ensure that any other internal requirements are met before submitting. Don’t forget to check with the  Office of Technology Management   to make sure your IP is suitably protected.


DoD.jpgExtension for FY 2021 Melanoma Research Program funding opportunities from the Department of Defense (DOD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP).

FY21 Funding Opportunities released: New deadlines for the Melanoma Research Program Opportunities
Letter of Intent due 5 pm ET 9 September 2021 and Full Application due 11:59 pm ET 28 September 2021!
  • Mid-Career Accelerator Award -$750,000 direct costs
  • Team Science Award - $700,000 direct costs
  • Translational Research Award - $600,000 direct costs with collaborator option $700,000 direct costs

FY21 Pre-announcements released: Reconstructive Transplant Research Program

  • Advanced Technology Development Award
  • Investigator-Initiated Research Award 
FY21 Funding Opportunities released: Combat Readiness—Medical Research Program
  • Rapid Development and Translational Research Award

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the Grants.gov website (https://Grants.gov).


 
Unknown-2.png
 
 
LIMITED SUBMISSION OPPORTUNITY
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
INTEROFFICE MEMORANDUM
 
Breast Cancer Alliance (BCA)
 
The mission of the Breast Cancer Alliance (BCA) is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To encourage a commitment to breast cancer research. To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists, including post docs, whose primary focus is breast cancer and who are in the early stages of their careers, to apply for funding for the Young Investigator Grant.
The University of Massachusetts Medical School may submit a maximum of TWO applications.
ELIGIBILITY
Applicants for 2022 grants must:
(1) not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2022
(2) not have been a principal investigator on an NIH R01 or equivalent national/international non-mentored award
(3) dedicate at least 50% of their work effort to research
 
For clarity, current postdoctoral fellows who do not yet hold a faculty position are eligible to apply, provided they meet all the other stated criteria for Young Investigators.
 
SPONSOR KEY DATES
Grant applications are due on or before July 23, 2021
Applicants will be notified in mid-February 2022 of the decision regarding their proposals.
 
FUNDING INFORMATION AND GRANT TERM
This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.
 
UMMS LIMITED SUBMISSION DEADLINE & APPLICATION PROCESS
Internal applications are due by June 18, 2021. Please submit the following information through the Limited Submission Application portal on the Office of Research website:
  • Brief summary of Candidate’s research plans (1 page)
  • Curriculum Vitae
  • A letter of support from Department Chair/Division Chief
For any questions on how to use the portal or submission assistance, please email Limited.Submissions@umassmed.edu.

 
Cures Within Reach
 
Cures Within Reach has a new funding opportunity to support Diversity, Equity and Inclusion in biomedical research by providing at least 3 grants to US-based racial/ethnic minority PIs for their clinical repurposing trials.
 
Looking for more info, click here to learn about:
  • Clinical repurposing trials in any disease led by a US-based racial / ethnic minority underrepresented in biomedical research (as defined by the NIH) are eligible
  • Projects must repurpose approved drugs, devices, nutraceuticals and/or diagnostics 
  • Budgets of up to $70,000 are accepted and at least 3 grants will be awarded
  • Requested funding can cover all costs or can supplement existing funding to help strengthen patient impact
  • PIs at any career stage are eligible to apply
  • Brief proposals submission are due by July 9, 2021 on our CureAccelator platform
  • Top-rated proposals will be invited to submit a full grant
To start a proposal, log intoCureAccelerator or sign up as a Researcher or Clinician.
 

Unknown-3.jpeg

The American Diabetes Association (ADA) is requesting applications for research (see RFA) focused on the impact of diabetes on health disparities and the impact of health disparities on diabetes and its complications.

According to the U.S. Department of Health and Human Services, health disparities are defined as differences in health that are closely linked with social or economic disadvantage. Health disparities adversely affect groups of people who have systematically experienced greater social and/or economic obstacles to health based on their racial or ethnic group; religion; socioeconomic status; gender; age; mental health; cognitive, sensory, or physical disability; sexual orientation; geographic location; or other characteristics historically linked to discrimination or exclusion.

Research Scope

For this funding opportunity, attention must focus on, and hypotheses should reflect, the impact of race/ethnicity, socioeconomic status, health care access, and/or other direct factors that underlie diabetes health disparities, and applications should describe how results of the proposed research will transform assessment and treatment of underserved groups and their potential to significantly improve outcomes in diabetes or its complications. The ADA encourages formative research, intervention development, and pilot-testing of interventions. For the purposes of this funding initiative, interventions may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent and/or improve clinical outcomes for people living with diabetes.

All applications must be submitted through our online grant portal. Please visit the ADA Research Programs website at https://professional.diabetes.org/content/targeted-rfas for full program details and application instructions for each grant type.Unknown-1.png